🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this study is to evaluate the safety, reactogenicity,...
Status
Completed
Location
Velocity Clinical Research
Start Date
2021-11-08
Trial ID
NCT05105048
Eighty percent of the Dutch population has completed a primary COVID-19 vac...
Status
Unknown
Location
AmsterdamUMC
Start Date
2022-08-20
Trial ID
NCT05471440
Treatments Being Tested
This phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnat...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07390968
This is a Phase 1 open label study to evaluate the tolerability, safety, im...
Status
Unknown
Location
Pindara Private Hospital
Start Date
2022-03-18
Trial ID
NCT05198752
Treatments Being Tested
For Phase 1 only. Additional information will be provided when Phase 2 is i...
Status
Unknown
Location
Center for Vaccine Development-Mali
Start Date
2022-06-02
Trial ID
NCT05490108
Treatments Being Tested
During the study, members of different online and offline communities will ...
Status
Unknown
Location
MEBO Research, Inc
Start Date
2021-01-05
Trial ID
NCT04832932
Treatments Being Tested
The primary goal for this study is to evaluate the safety and reactogenicit...
Status
Completed
Location
Synexus Clinical Research US Phoenix Southeast, Inc.
Start Date
2021-03-11
Trial ID
NCT04813796
The primary objective of this study is to evaluate the immunogenicity and s...
Status
Active Not Recruiting
Location
Baise Center For Disease Control & Prevention
Start Date
2025-09-15
Trial ID
NCT07289542
The objective will be to analyze the development of cellular and humoral im...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT04930770
Treatments Being Tested
This is an open-label, single-arm, dose-escalation, and dose-expansion clin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2023-09-28
Trial ID
NCT06088004
Treatments Being Tested